News

CENTOGENE’s CentoCloud® Set to Revolutionize Rare Disease Diagnostics With Decentralized SaaS Platform for Laboratories Around the World

Jan 04, 2022

The CentoCloud solution is a cloud-based Software as a Service (SaaS) platform that enables laboratories around the...

CENTOGENE Wins Award in Digital Healthcare Innovation for Artificial Intelligence (AI) Platform Leading Biomarker Discovery

Dec 23, 2021

Leveraging AI to Accelerate the Path From Diagnosis to Cure

CENTOGENE Announces CEO to Take Temporary Medical Leave of Absence – Biopharmaceutical Industry Veteran Kim Stratton Appointed as Interim CEO

Dec 20, 2021

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, December 20, 2021 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a...

CENTOGENE Reports Third Quarter 2021 Financial Results

Nov 24, 2021

Second Consecutive Quarter of Core Business Growth, Phasing Out COVID-19 Testing and Restructuring Organization for Core...

CENTOGENE to Announce Third Quarter 2021 Financial Results on November 24, 2021

Nov 18, 2021

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, November 18, 2021 (GLOBE NEWSWIRE) - Centogene N.V. (Nasdaq: CNTG), a...

CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Diseases

Nov 04, 2021

Providing Global Clinical Trial Support for Thalassemia and Sickle Cell Disease Will Deepen Understanding of Disease...

CENTOGENE Enrolls First Patient in Frontotemporal Dementia (FTD) Clinical Study

Oct 28, 2021

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, October 28, 2021 (GLOBE NEWSWIRE)

FTD is a rapidly progressing...

CENTOGENE and Twist Bioscience to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases

Oct 06, 2021

Combining Expertise to Advance Precision Medicine, While Enabling a More Efficient and Timely Diagnosis of Rare...

CENTOGENE’s Ground-Breaking Family Genetic Research Published in the New England Journal of Medicine Reveals Path to Potential Cure for Structural Birth Defects

Sep 29, 2021

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 29, 2021 (GLOBE NEWSWIRE)

Collaborative research utilized...

CENTOGENE Reports Second Quarter 2021 Financial Results

Sep 07, 2021

Strong Revenues and Steady Return to Core Business Growth; Surpasses Milestone of 200 Scientific Publications,...

1
2
3
....
25
Next

Press Contact

For further inquiries please contact:

Ben Legg

Corporate Communications

Send Email

Subscribe to our Newsletter

First Name

Last Name

Email *

Country

To receive the latest news and developments in clinical diagnostics and scientific breakthroughs in the rare disease field please click subscribe. After that, you will receive an email with a confirmation link. Once you have clicked on that link, we will inform you about our products, services and upcoming events per e-mail. You can unsubscribe from the newsletter with effect for the future at any time using the unsubscribe link contained in every newsletter.

Scientific articles

Defining the Clinical Spectrum of Rare Disorders

Many rare disorders, despite being considered syndromic, may manifest with only a single clinical symptom. A CENTOGENE-led epidemiological clinical study provided impressive evidence for the relevance of this phenomenon…

Article Oct 16, 2021 with topic NGS, Neurology, Cardiovascular

Read more
Linking Seizures and Amino Acid Homeostasis

Seizures are part of the phenotypic spectrum in numerous rare disorders, but the underlying pathophysiology is rarely understood. For a novel seizure syndrome, the transmembrane transport of certain amino acids could now…

Article Oct 04, 2021 with topic WES, WGS, Mutation Database, Neurology

Read more
Combining Genetic Insights and Therapeutic Efforts

The delineation of a novel rare disease is commonly a stand-alone research project. An international consortium, in which CENTOGENE played a major role, showcased how disease discovery can conceptually be combined with…

Article Sep 30, 2021 with topic WES, WGS, Mutation Database

Read more